GENE ONLINE|News &
Opinion
Blog

In-Depth
Moving Beyond COVID With mRNA Technology
2023-01-18
2023 Trend Forecast: Transforming Healthcare with Real-world Data and Personalized Medicine
2023-01-05
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
64th ASH Annual Meeting and Exposition: Standard Treatments Face Challenges
2022-12-29
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
Moving Past Animal Models with Better Data for Drug Discovery
2022-11-23Partner
BioFuture NYC 2022: Using Technology to Prepare for an Aging Population
2022-11-22
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates
2022-11-17Partner
Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone
2022-11-15
Leveraging Synthetic Biology, Microbiome-based Therapies Open Up Possibilities for Clinical Applications
2022-10-20
Synthetic Biology: A Rising Interdisciplinary Field that Revolutionizes the Biomedical Industry
2022-10-19
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
2026: The Promise of Synthetic Biology
2022-08-11
Innovating Drug Delivery Systems with Moderna’s Bob Langer
2022-07-26
1 2 3 9
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!